Bis[1-cyclopropyl-6-fluoro-4-oxo-7-(1-piperazin-4-ium-1-yl)-1,4-dihydroquinoline-3-carboxylate-κ2 O 3,O 4]bis(nitrato-κO)copper(II)
In the title complex, [Cu(NO3)2(C17H18FN3O3)2], the CuII ion is located on an inversion center. It exhibits a distorted octahedral geometry, being coordinated by six O atoms, four from two ciprofloxacin ligand molecules (L), which act as bidentate ligands, and two from two nitrate anions. In the l...
| Main Authors: | , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
International Union of Crystallography
2012
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3297282/ |
| id |
pubmed-3297282 |
|---|---|
| recordtype |
oai_dc |
| spelling |
pubmed-32972822012-03-12 Bis[1-cyclopropyl-6-fluoro-4-oxo-7-(1-piperazin-4-ium-1-yl)-1,4-dihydroquinoline-3-carboxylate-κ2 O 3,O 4]bis(nitrato-κO)copper(II) Yang, Juan Yan, Shi-Wei Ye, Zhong-Li Xin, Guang-Hua Chang, Suo-Cheng Metal-Organic Papers In the title complex, [Cu(NO3)2(C17H18FN3O3)2], the CuII ion is located on an inversion center. It exhibits a distorted octahedral geometry, being coordinated by six O atoms, four from two ciprofloxacin ligand molecules (L), which act as bidentate ligands, and two from two nitrate anions. In the ligand, the piperazine ring has a chair conformation and the quinoline system is essentially planar [maximum deviation = 0.097 (2) Å]. One of the nitrate O atoms is disordered over two positions [occupancy ratio = 0.51 (6):0.49 (6)]. There is a C—H⋯F interaction in the complex. In the crystal, molecules are linked via N—H⋯O hydrogen bonds generating a two-dimensional network lying parallel to (111). The presence of C—H⋯O interactions leads to the formation of a three-dimensional structure. The title complex was prepared by hydrothermal synthesis, and the hexahydrate form of this complex, synthesized by conventional methods, has been reported previously [Hernandez-Gil et al. (2009 ▶). Polyhedron, 28, 138–144]. International Union of Crystallography 2012-02-29 /pmc/articles/PMC3297282/ /pubmed/22412472 http://dx.doi.org/10.1107/S1600536812007830 Text en © Yang et al. 2012 http://creativecommons.org/licenses/by/2.0/uk/ This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited. |
| repository_type |
Open Access Journal |
| institution_category |
Foreign Institution |
| institution |
US National Center for Biotechnology Information |
| building |
NCBI PubMed |
| collection |
Online Access |
| language |
English |
| format |
Online |
| author |
Yang, Juan Yan, Shi-Wei Ye, Zhong-Li Xin, Guang-Hua Chang, Suo-Cheng |
| spellingShingle |
Yang, Juan Yan, Shi-Wei Ye, Zhong-Li Xin, Guang-Hua Chang, Suo-Cheng Bis[1-cyclopropyl-6-fluoro-4-oxo-7-(1-piperazin-4-ium-1-yl)-1,4-dihydroquinoline-3-carboxylate-κ2 O 3,O 4]bis(nitrato-κO)copper(II) |
| author_facet |
Yang, Juan Yan, Shi-Wei Ye, Zhong-Li Xin, Guang-Hua Chang, Suo-Cheng |
| author_sort |
Yang, Juan |
| title |
Bis[1-cyclopropyl-6-fluoro-4-oxo-7-(1-piperazin-4-ium-1-yl)-1,4-dihydroquinoline-3-carboxylate-κ2
O
3,O
4]bis(nitrato-κO)copper(II) |
| title_short |
Bis[1-cyclopropyl-6-fluoro-4-oxo-7-(1-piperazin-4-ium-1-yl)-1,4-dihydroquinoline-3-carboxylate-κ2
O
3,O
4]bis(nitrato-κO)copper(II) |
| title_full |
Bis[1-cyclopropyl-6-fluoro-4-oxo-7-(1-piperazin-4-ium-1-yl)-1,4-dihydroquinoline-3-carboxylate-κ2
O
3,O
4]bis(nitrato-κO)copper(II) |
| title_fullStr |
Bis[1-cyclopropyl-6-fluoro-4-oxo-7-(1-piperazin-4-ium-1-yl)-1,4-dihydroquinoline-3-carboxylate-κ2
O
3,O
4]bis(nitrato-κO)copper(II) |
| title_full_unstemmed |
Bis[1-cyclopropyl-6-fluoro-4-oxo-7-(1-piperazin-4-ium-1-yl)-1,4-dihydroquinoline-3-carboxylate-κ2
O
3,O
4]bis(nitrato-κO)copper(II) |
| title_sort |
bis[1-cyclopropyl-6-fluoro-4-oxo-7-(1-piperazin-4-ium-1-yl)-1,4-dihydroquinoline-3-carboxylate-κ2
o
3,o
4]bis(nitrato-κo)copper(ii) |
| description |
In the title complex, [Cu(NO3)2(C17H18FN3O3)2], the CuII ion is located on an inversion center. It exhibits a distorted octahedral geometry, being coordinated by six O atoms, four from two ciprofloxacin ligand molecules (L), which act as bidentate ligands, and two from two nitrate anions. In the ligand, the piperazine ring has a chair conformation and the quinoline system is essentially planar [maximum deviation = 0.097 (2) Å]. One of the nitrate O atoms is disordered over two positions [occupancy ratio = 0.51 (6):0.49 (6)]. There is a C—H⋯F interaction in the complex. In the crystal, molecules are linked via N—H⋯O hydrogen bonds generating a two-dimensional network lying parallel to (111). The presence of C—H⋯O interactions leads to the formation of a three-dimensional structure. The title complex was prepared by hydrothermal synthesis, and the hexahydrate form of this complex, synthesized by conventional methods, has been reported previously [Hernandez-Gil et al. (2009 ▶). Polyhedron, 28, 138–144]. |
| publisher |
International Union of Crystallography |
| publishDate |
2012 |
| url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3297282/ |
| _version_ |
1611511558582566912 |